Format

Send to

Choose Destination
Emerg Infect Dis. 2004 Dec;10(12):2218-20.

Protective effectiveness of hantavirus vaccine.

Author information

1
National Cancer Center, Goyang, Republic of Korea. bachism@empal.com

Abstract

A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.

PMID:
15663866
PMCID:
PMC3323375
DOI:
10.3201/eid1012.040684
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for CDC-NCEZID Icon for PubMed Central
Loading ...
Support Center